WEINSTEIN ROBERT
Transaction: 03/31/2026
BUY
Change
0
Price
Not reported
Filing
07/17/2026
Type
BUY
PharmaCyte Biotech, Inc.
PMCB • Biotechnology
$0.49
— 0.00 (0.00%)
EarningsLatest report: Apr 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.51M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 45.28Weak profitability
Financial data as of: Apr 30, 2026, 12:00 AM UTCLast earnings update: Apr 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.49
Change0.00%
Shares Out9.26M
Market Cap$4.51M
Enterprise Value$-18.86T
52W Range0.55 - 1.51
Beta0.52
P/E-1.37
P/B0.00
P/FCF-0.00
EV/EBITDA1,462,293.90
EV/FCF3.66
Price$0.49
Change0.00%
Shares Out9.26M
Market Cap$4.51M
Enterprise Value$-18.86T
52W Range0.55 - 1.51
Beta0.52
P/E-1.37
P/B0.00
P/FCF-0.00
EV/EBITDA1,462,293.90
EV/FCF3.66
Earnings Yield-72.82%
Dividend Yield4.09%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio45.28
Quick Ratio45.28
Volume613.07K
Avg Volume176.07K
EPS Surprise0.19
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 45.28Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
50/100
Neutral
Bullish
0
Hold
1
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
SCHECHTER JONATHAN
Transaction: 03/31/2026
BUY
Change
0
Price
Not reported
Filing
07/17/2026
Type
BUY
Abecassis Michael M
Transaction: 03/31/2026
BUY
Change
0
Price
Not reported
Filing
07/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| WEINSTEIN ROBERT | BUY | 0 | Not reported | 03/31/2026 | 07/17/2026 |
| SCHECHTER JONATHAN | BUY | 0 | Not reported | 03/31/2026 | 07/17/2026 |
| Abecassis Michael M | BUY | 0 | Not reported | 03/31/2026 | 07/17/2026 |
| WALKER WAYNE REMELL | BUY | 0 | Not reported | 03/31/2026 | 07/17/2026 |
| Abecassis Michael M | BUY | +119,170 | $0.67 | 03/31/2026 | 04/02/2026 |
| SCHECHTER JONATHAN | BUY | +119,170 | $0.67 | 03/31/2026 | 04/02/2026 |
| WALKER WAYNE REMELL | BUY | +119,170 | $0.67 | 03/31/2026 | 04/02/2026 |
| WEINSTEIN ROBERT | BUY | +119,170 | $0.67 | 03/31/2026 | 04/02/2026 |
| SCHECHTER JONATHAN | BUY | +20,000 | $0.84 | 01/07/2026 | 01/07/2026 |
| Silverman Joshua | BUY | +40,000 | $0.83 | 01/07/2026 | 01/07/2026 |
| SCHECHTER JONATHAN | BUY | +20,000 | $0.79 | 01/06/2026 | 01/07/2026 |
| Silverman Joshua | BUY | +30,000 | $0.79 | 01/06/2026 | 01/07/2026 |
| SCHECHTER JONATHAN | BUY | +20,000 | $0.78 | 01/05/2026 | 01/07/2026 |
| Silverman Joshua | BUY | +30,000 | $0.78 | 01/05/2026 | 01/07/2026 |
| Abecassis Michael M | SELL | -16,875 | $1.02 | 12/12/2025 | 12/12/2025 |
| SCHECHTER JONATHAN | SELL | -67,500 | $1.02 | 12/12/2025 | 12/12/2025 |
| Silverman Joshua | SELL | -258,750 | $1.02 | 12/12/2025 | 12/12/2025 |
| WALKER WAYNE REMELL | SELL | -16,875 | $1.02 | 12/12/2025 | 12/12/2025 |
| WEINSTEIN ROBERT | SELL | -33,750 | $1.02 | 12/12/2025 | 12/12/2025 |
| Abecassis Michael M | BUY | +63,233 | $1.22 | 04/25/2025 | 12/12/2025 |